(-0.51%) 5 081.50 points
(-0.34%) 38 548 points
(-0.82%) 17 519 points
(-0.22%) $82.63
(-0.24%) $1.649
(0.01%) $2 338.70
(0.18%) $27.40
(0.21%) $917.70
(-0.24%) $0.932
(-0.28%) $10.95
(-0.41%) $0.799
(-0.14%) $92.19
Live Chart Being Loaded With Signals
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis...
Stats | |
---|---|
Today's Volume | 9 535.00 |
Average Volume | 52 099.00 |
Market Cap | 32.50M |
EPS | €0 ( 2024-04-24 ) |
Next earnings date | ( €0 ) 2024-06-26 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -9.18 |
ATR14 | €0.0150 (1.49%) |
Abionyx Pharma SA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abionyx Pharma SA Financials
Annual | 2023 |
Revenue: | €4.60M |
Gross Profit: | €600 000 (13.04 %) |
EPS: | €-0.110 |
Q4 | 2023 |
Revenue: | €2.47M |
Gross Profit: | €611 000 (24.72 %) |
EPS: | €-0.0393 |
Q3 | 2023 |
Revenue: | €1.24M |
Gross Profit: | €305 500 (24.72 %) |
EPS: | €0 |
Q2 | 2023 |
Revenue: | €2.13M |
Gross Profit: | €-30 000.00 (-1.41 %) |
EPS: | €-0.0791 |
Financial Reports:
No articles found.
Abionyx Pharma SA
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators